Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 19, 2024Frontiers in OncologyOpen Access

The two-faced role of RNA methyltransferase METTL3 on cellular response to cisplatin in head and neck squamous cell carcinoma in vitro model

View Full Paper
Ask AI
Bookmark
Share

Authors

KOKamila OstrowskaARAgnieszka Anna Rawłuszko-WieczorekJOJulia Ostapowicz

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ostrowska et al. (2024) studied this question.

synapsesocial.com/papers/68e6417fb6db6435875d2f82https://doi.org/10.3389/fonc.2024.1402126
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Analysis of the Oncogenic Role of Methyltransferase Like 3 (METLL3) in Head and Neck Squamous Cell Carcinoma (HNSCC)2024 · 1 citations
  2. 2METTL3 as a potential predictive biomarker for immunotherapy response in metastatic head and neck cancer.2024
  3. 3Abstract 7485: RNA modification control of platinum sensitivity via ADAM23-dependent pathway2026
  4. 4Abstract 3233: EP102: Pharmacological Inhibition of METTL3 causes tumor growth inhibition and prolongs survival in preclinical models of NSCLC, ovarian and squamous cell carcinoma2024
  5. 5Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications2024 · 11 citations